How we collect and check the data
Which trials are included?
Initial coverage focuses on company-sponsored Phase 2/3 drug trials linked to US-listed companies. We add coverage as we verify sources and company links. Counts on the site describe records in our database, not every trial or every company program.
How far back does the history go?
The original research archive contains 1,642 trials and 14,436 selected field versions. Those are archive counts, not current database totals. The archive saves selected fields from selected versions, so it can miss changes. Some primary outcome text was shortened to 300 characters by the research collector. Trial pages explain the available history. Older records are imported separately; opening a page does not fetch missing historical versions.
What does a recorded change tell me?
It tells you that a value or text in the trial record changed. It does not establish why it changed or whether the change matters scientifically or commercially. In a manual check of 30 flagged primary outcome edits, 19 were substantive and 11 were rewordings. We label unreviewed changes as text edits.
Which dates am I seeing?
A trial record can be submitted on one date and posted publicly on another. Change histories show the saved posting date when available. A trial’s completion date may still be an estimate. Company statistics describe only the trials we cover, not the company’s complete track record.
What is in the FDA calendar?
We publish events backed by source records and linked to companies and drugs we track. Sources include company filings with the US Securities and Exchange Commission (SEC), FDA drug and biologic approval publications, complete response letters and advisory committee notices. Records with uncertain matches or conflicting evidence stay unpublished. The calendar shows when sources were scanned; a completed scan does not mean we found every event in the market.
How are regulatory events checked?
AI-assisted checks compare possible events with the cited original source and the company or drug involved. Automated checks can make mistakes, so we provide the sources for you to inspect.